Image (0674943f 7498 497e B788 A9f12e62383d 112 1)
Kyxata
Product Images NDC 83831-140
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Kyxata (NDC 83831-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 01)
Chemical structure of the active ingredient in KYXATA, 500 mg/50 mL and 80 mg/8 mL, by Avyxa Pharma, LLC. The structure shows a platinum (Pt) complex with amine groups and cyclobutane dicarboxylate ligands.*
Kyxata (carboplatin) Injection, 20 mg/2 mL (10 mg/ml) -vial Label (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 02)
KYXATA (CARBOplatin) Injection 20 mg/2 mL (10 mg/mL) label for intravenous use. This sterile, hazardous drug is supplied in a 2 mL multiple-dose vial. The label includes storage instructions, no preservatives statement, manufacturer Avyxa Pharma, LLC, and a barcode with spaces for lot number and expiration date.*
Kyxata (carboplatin) Injection, 20 mg/2 mL (10 mg/ml) -carton Label (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 03)
Carton label for KYXATA (Carboplatin) Injection 20 mg/2 mL (10 mg/mL) by Avyxa Pharma, LLC. The label indicates a 2 mL multiple-dose vial for intravenous use, marked as a hazardous drug. Storage instructions and manufacturer details (Made in Switzerland) are included, along with barcodes and space for batch details and expiration date.*
Kyxata (carboplatin) Injection, 80 mg/8 mL (10 mg/ml) -vial Label (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 04)
Label for KYXATA (CARBOplatin) Injection 80 mg/8 mL (10 mg/mL) multiple-dose vial. The sterile intravenous injection vial contains 8 mL and is marked as a hazardous drug for prescription use only. Label includes storage instructions, manufacturer Avyxa Pharma, LLC, barcode, and space for lot number and expiration date.*
Kyxata (carboplatin) Injection, 80 mg/8 mL (10 mg/ml) -carton Label (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 05)
KYXATA 80 mg/8 mL (10 mg/mL) Injection label for an 8 mL multiple-dose vial. The product is for intravenous use and labeled as a hazardous drug. Manufactured for Avyxa Pharma, LLC, the label includes dosage information, storage instructions, a barcode, and the manufacturer's logo. The carton art features white and teal colors with black and red text.*
Kyxata (carboplatin) Injection, 500 mg/50 mL (10 mg/ml) -vial Label (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 06)
Label for KYXATA (Carboplatin) Injection 500 mg/50 mL (10 mg/mL) sterile solution for intravenous use. The label states it is a hazardous drug, prescription use only, and contains storage instructions. It is manufactured by Avyxa Pharma, LLC, made in Switzerland, and includes barcode and lot, expiration date areas.*
Kyxata (carboplatin) Injectionn, 500 mg/50 mL (10 mg/ml) -carton Label (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 07)
Packaging label for KYXATA (Carboplatin) Injection 500 mg/50 mL (10 mg/mL). The label indicates this is a sterile, hazardous drug for intravenous use available in a 50 mL multiple-dose vial. The labeler is Avyxa Pharma, LLC. Storage, usage, and discard instructions are included. The label states the product is manufactured in Switzerland.*
Image (1960f327 Faf2 49b2 B6ad Df9340c0ebc3 178 2)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
